Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Chronic Renal Failure: later-stage trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Chronic Renal Failure: 2 US clinical trials tracked, none currently recruiting.

Chronic Renal Failure is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Affymax, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-renal-failure

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Chronic Renal Failure (this)0%
Open-enrollment share among volume-matched conditions near Chronic Renal Failure

Chronic Renal Failure has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Renal Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Renal Failure is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Affymax 1 trials
Vantive Health 1 trials

Named interventions

Most-linked intervention names on Chronic Renal Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

On line hemodiafiltration Device
1 trials
On line hemofiafiltration Device
1 trials
peginesatide Drug
1 trials
Epoetin Alfa Drug
1 trials

US sites by state

Facility locations filed on Chronic Renal Failure trials. A trial with sites in several states counts in each.

Florida 1 trials
Connecticut 1 trials
Colorado 1 trials
California 1 trials
Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Renal Failure page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Chronic Renal Failure trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Affymax sponsors the most Chronic Renal Failure trials on record, review their full trial history before evaluating a specific study. See Affymax's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Renal Failure condition card totals 2 registered trials; most-linked intervention On line hemodiafiltration; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.